With US government supplies of Covid vaccines predicted to run out in the first quarter…
Latest news
Bristol-Myers Squibb is going after a second indication for its first-to-market cardiac myosin inhibitor Camzyos,…
Companies who are thinking about seeking funding via England’s new Innovative Medicines Fund (IMF) need…
The Medicines Patent Pool (MPP) and Novartis have unveiled a new voluntary licensing agreement to…
The acquisition of DJS Antibodies, a privately-held UK-based biotechnology company dedicated to discovering and developing…
Swiss pharma giant Roche has moved to strengthen its position in the KRAS-mutated cancer space…
Young adults with depression have been treated effectively with a cognitive behavioural therapy (CBT) course…
The UK company reveals the results from a partner-led survey to discover the rates of…
And the LIVE coverage continues as we head into Day Two… This day is set…
Lung, breast, and non-prostate genitourinary (NGU) cancer treatments were the most exciting tracks due to…
In mid-October, our Web Editor Nicole Raleigh and Deep Dive Editor Eloise McLennan travelled to…
In response to the recent Association of British Pharmaceutical Industry (ABPI) report, which showed a…
Executing an effective commercial success strategy requires extensive planning and implementation within pharmaceutical companies that…
Frontiers Health 2022 in Milan is LIVE! Opening Day One will be Healthware Group’s CEO…
Jazz Pharmaceuticals and Zymeworks, Inc. have announced that Jazz and Zymeworks BC, Inc. (a Zymeworks…
UK biotech Nucleome Therapeutics has been thrust into the spotlight thanks to a £37.5 million…
CVS Health recently acquired home healthcare agency, Signify Health, for a whopping $8 billion. With…
Patients across the UK with chronic immune thrombocytopenia (ITP) now have another treatment option, after…
From diagnosis to treatment and ongoing condition management, the patient journey is becoming an increasingly…
Image: Laura Holmes Haddad It was the summer of 2012 and I had just turned…
Yesterday, global provider of patient-centric data analytics, Phesi launched its AI-driven Trial Accelerator Platform, an…
Synthetic biology specialist Synlogic will start phase 3 testing of a drug for rare metabolic…
Hard on the heels of the official launch of its digital disease management platform, Aptar…
- Pharma News
Every scientific message has a story. Medical communications must adapt to effectively bring these to life.
Medical communications are in a state of transition. Due to the combined impact of emerging…
Emma Hyland, VP strategy, commercial content at Veeva Systems, tells us modular content is the…
Eli Lilly has agreed to buy hearing loss gene therapy developer Akouos in a deal…
Medtech giant Beckton Dickinson (BD) has signed a deal with France’s Biocorp to use the…
As the Frontiers Health 2022 conference in Milan on 20th to 21st October approaches this…
Oculis SA, a global biopharmaceutical company that develops treatments for saving sight and improving eye…
One of the first actions by GSK’s recently-appointed chief scientific officer Tony Wood has been…
Gilead Sciences has made yet another rush into the oncology category, licensing a bispecific antibody…
Roche’s third-quarter results have revealed a clear sign that the bumper sales boosting companies that…
Now that the COVID-19 pandemic has provided the industry with a solid foundation of experience…
The FDA is planning to take an additional three months to review Biogen’s experimental therapy…
This post was originally published on Source Link
There’s no doubt that self-injection devices have transformed the lives of people with chronic diseases…
Bayer has added another clinical trial to its extensive phase 3 programme for oral neurokinin…
The European Medicines Agency (EMA) Committee for Medicinal Products for Human Use (CHMP) has adopted…
Atara Biotherapeutics’ cell therapy Ebvallo should be approved to treat Epstein-Barr virus-positive post-transplant lymphoproliferative disease…
Novartis’ hopes that the Supreme Court would protect its big-selling multiple sclerosis drug Gilenya from…
When James P Allison and Tasuku Honjo were awarded the Nobel Prize for Medicine in…
- Pharma News
Gene therapies for prevalent diseases in Europe – the perfect storm of economic sustainability?
In this article, Research Partnership reviews why the path to commercialisation for the half a…
Bayer’s big-selling contraceptive Mirena has been approved in Europe to provide up to eights years…
Biotech company Odyssey Therapeutics, Inc. has announced a $168 million Series B financing, led by…
A consortium of industry and academic groups – led by Johnson & Johnson’s pharma division…
Otonomy has chalked up its second clinical trial failure in the space of a few…
Day 3 coverage: Click here to read Reuters: Pharma 2022 Day 1 overview Click here…
As the only industry-led forum providing biopharma with the insights necessary to make strategic and…
Oliver Stohlmann’s Corporate Survival Hacks series draws on his experiences of working in local, regional,…
The US authorities have authorised use of two bivalent COVID-19 booster vaccines from Pfizer/BioNTech and…